Replies to Post #191356 onBiotech Values

Replies to post #191356 on Biotech Values

Replies to #191356 on Biotech Values

05/20/15 10:54 AM

#191529 RE: DewDiligence #191356

JNJ’s PR accompanying today’s Pharma Business Review:

http://finance.yahoo.com/news/johnson-johnson-pharmaceutical-segment-continue-113000526.html

Mentions AL-335 only in passing.

05/20/15 11:51 AM

#191535 RE: DewDiligence #191356

JNJ’s Husseini Manji is talking about the Bapineuzumab follow-on compound.

05/20/15 3:48 PM

#191542 RE: DewDiligence #191356

ADRO +4% /ADXS +6%. JNJ mentioned ADRO prominently during the oncology section of today’s Pharma Business Review.